Replimune Group Stock Operating Margin
REPL Stock | USD 6.59 0.18 2.81% |
Replimune Group fundamentals help investors to digest information that contributes to Replimune's financial success or failures. It also enables traders to predict the movement of Replimune Stock. The fundamental analysis module provides a way to measure Replimune's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Replimune stock.
Replimune |
Replimune Group Company Operating Margin Analysis
Replimune's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition |
Based on the recorded statements, Replimune Group has an Operating Margin of 0.0%. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The operating margin for all United States stocks is 100.0% lower than that of the firm.
Replimune Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Replimune's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Replimune could also be used in its relative valuation, which is a method of valuing Replimune by comparing valuation metrics of similar companies.Replimune is currently under evaluation in operating margin category among related companies.
Replimune Fundamentals
Return On Equity | -0.41 | ||||
Return On Asset | -0.23 | ||||
Current Valuation | 2.96 M | ||||
Shares Outstanding | 61.39 M | ||||
Shares Owned By Insiders | 5.79 % | ||||
Shares Owned By Institutions | 94.21 % | ||||
Number Of Shares Shorted | 8.47 M | ||||
Price To Book | 1.04 X | ||||
EBITDA | (177.4 M) | ||||
Net Income | (174.28 M) | ||||
Cash And Equivalents | 395.08 M | ||||
Cash Per Share | 8.01 X | ||||
Total Debt | 60.76 M | ||||
Debt To Equity | 0.08 % | ||||
Current Ratio | 19.79 X | ||||
Book Value Per Share | 6.87 X | ||||
Cash Flow From Operations | (128.05 M) | ||||
Short Ratio | 10.40 X | ||||
Earnings Per Share | (3.16) X | ||||
Target Price | 13.56 | ||||
Number Of Employees | 284 | ||||
Beta | 1.25 | ||||
Market Capitalization | 393.5 M | ||||
Total Asset | 646.59 M | ||||
Retained Earnings | (485.49 M) | ||||
Working Capital | 558.78 M | ||||
Net Asset | 646.59 M |
About Replimune Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Replimune Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Replimune using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Replimune Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Replimune Group is a strong investment it is important to analyze Replimune's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Replimune's future performance. For an informed investment choice regarding Replimune Stock, refer to the following important reports:Check out Replimune Piotroski F Score and Replimune Altman Z Score analysis. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Replimune Stock analysis
When running Replimune's price analysis, check to measure Replimune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Replimune is operating at the current time. Most of Replimune's value examination focuses on studying past and present price action to predict the probability of Replimune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Replimune's price. Additionally, you may evaluate how the addition of Replimune to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Transaction History View history of all your transactions and understand their impact on performance | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is Replimune's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Replimune. If investors know Replimune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Replimune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Replimune Group is measured differently than its book value, which is the value of Replimune that is recorded on the company's balance sheet. Investors also form their own opinion of Replimune's value that differs from its market value or its book value, called intrinsic value, which is Replimune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Replimune's market value can be influenced by many factors that don't directly affect Replimune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Replimune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Replimune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Replimune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.